231 related articles for article (PubMed ID: 8546422)
61. Findings of multiple muscle involvement in a study of 214 patients with laryngeal dystonia using fine-wire electromyography.
Klotz DA; Maronian NC; Waugh PF; Shahinfar A; Robinson L; Hillel AD
Ann Otol Rhinol Laryngol; 2004 Aug; 113(8):602-12. PubMed ID: 15330138
[TBL] [Abstract][Full Text] [Related]
62. Unilateral versus bilateral thyroarytenoid Botulinum toxin injections in adductor spasmodic dysphonia: a prospective study.
Upile T; Elmiyeh B; Jerjes W; Prasad V; Kafas P; Abiola J; Youl B; Epstein R; Hopper C; Sudhoff H; Rubin J
Head Face Med; 2009 Oct; 5():20. PubMed ID: 19852852
[TBL] [Abstract][Full Text] [Related]
63. Laryngeal electromyography in movement disorders: preliminary data.
Kimaid PA; Quagliato EM; Crespo AN; Wolf A; Viana MA; Resende LA
Arq Neuropsiquiatr; 2004 Sep; 62(3A):741-4. PubMed ID: 15334243
[TBL] [Abstract][Full Text] [Related]
64. Does botulinum toxin alter laryngeal secretions and mucociliary transport?
Fisher KV; Giddens CL; Gray SD
J Voice; 1998 Sep; 12(3):389-98. PubMed ID: 9763190
[TBL] [Abstract][Full Text] [Related]
65. Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia.
Casserly P; Timon C
J Laryngol Otol; 2008 Jan; 122(1):52-6. PubMed ID: 17470307
[TBL] [Abstract][Full Text] [Related]
66. Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox).
Brin MF; Blitzer A; Fahn S; Gould W; Lovelace RE
Mov Disord; 1989; 4(4):287-96. PubMed ID: 2811888
[TBL] [Abstract][Full Text] [Related]
67. Partial thyroarytenoid myectomy: an animal study investigating a proposed new treatment for adductor spasmodic dysphonia.
Genack SH; Woo P; Colton RH; Goyette D
Otolaryngol Head Neck Surg; 1993 Mar; 108(3):256-64. PubMed ID: 8464639
[TBL] [Abstract][Full Text] [Related]
68. Laryngeal image analysis following botulinum toxin injections in spasmodic dysphonia.
Wong DL; Irish JC; Adams SG; Durkin LC; Hunt EJ
J Otolaryngol; 1995 Feb; 24(1):64-8. PubMed ID: 7769649
[TBL] [Abstract][Full Text] [Related]
69. Resistance to botulinum toxin injections for spasmodic dysphonia.
Smith ME; Ford CN
Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):533-5. PubMed ID: 10772310
[TBL] [Abstract][Full Text] [Related]
70. Quantitative mapping of the effect of botulinum toxin injections in the thyroarytenoid muscle.
George EF; Zimbler M; Wu BL; Biller HF; Sanders I
Ann Otol Rhinol Laryngol; 1992 Nov; 101(11):888-92. PubMed ID: 1444095
[TBL] [Abstract][Full Text] [Related]
71. Abductor laryngeal dystonia: a series treated with botulinum toxin.
Blitzer A; Brin MF; Stewart C; Aviv JE; Fahn S
Laryngoscope; 1992 Feb; 102(2):163-7. PubMed ID: 1738288
[TBL] [Abstract][Full Text] [Related]
72. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
73. Longitudinal phonatory characteristics after botulinum toxin type A injection.
Fisher KV; Scherer RC; Guo CG; Owen AS
J Speech Hear Res; 1996 Oct; 39(5):968-80. PubMed ID: 8898251
[TBL] [Abstract][Full Text] [Related]
74. Unilateral versus bilateral injections of botulinum toxin in patients with adductor spasmodic dysphonia.
Bielamowicz S; Stager SV; Badillo A; Godlewski A
J Voice; 2002 Mar; 16(1):117-23. PubMed ID: 12002878
[TBL] [Abstract][Full Text] [Related]
75. Botulinum toxin for spasmodic dysphonia.
Rodriquez AA
Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):767-79. PubMed ID: 14580036
[TBL] [Abstract][Full Text] [Related]
76. Treatment efficacy of electromyography versus fiberscopy-guided botulinum toxin injection in adductor spasmodic dysphonia patients: a prospective comparative study.
Kim JW; Park JH; Park KN; Lee SW
ScientificWorldJournal; 2014; 2014():327928. PubMed ID: 25383369
[TBL] [Abstract][Full Text] [Related]
77. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality.
Tsuji DH; Takahashi MT; Imamura R; Hachiya A; Sennes LU
J Voice; 2012 Sep; 26(5):666.e7-12. PubMed ID: 21940146
[TBL] [Abstract][Full Text] [Related]
78. Botulinum toxin therapy for abductor spasmodic dysphonia.
Woodson G; Hochstetler H; Murry T
J Voice; 2006 Mar; 20(1):137-43. PubMed ID: 16126369
[TBL] [Abstract][Full Text] [Related]
79. Botulinum toxin A and B: a comparative dosing study for spasmodic dysphonia.
Blitzer A
Otolaryngol Head Neck Surg; 2005 Dec; 133(6):836-8. PubMed ID: 16360499
[TBL] [Abstract][Full Text] [Related]
80. Botulinum toxin treatment for spasmodic dysphonia.
Kobayashi T; Niimi S; Kumada M; Kosaki H; Hirose H
Acta Otolaryngol Suppl; 1993; 504():155-7. PubMed ID: 8470525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
